Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Interventions to safely and effectively reduce (taper) use of opioids in chronic non-cancer pain: a systematic review›Search results for all reviews

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Interventions to safely and effectively reduce (taper) use of opioids in chronic non-cancer pain: a systematic review · Search results for all reviews

Search results for all reviews

CC BY 4.0 · National Institute for Health and Care Research · approximately 2 min read

The results of the searches and study selection are presented in Figure 1. The initial and updated searches identified 16,434 unique records to be screened, and of these 15,574 papers were excluded as they did not fulfil the inclusion criteria. The full-text copies of the remaining 860 papers, plus an additional 6 papers identified through hand-searching, were obtained and the inclusion criteria were applied independently by at least 2 reviewers. At this stage, 728 papers were excluded as they did not fulfil the inclusion criteria. A further 52 studies were excluded once reviewers began to extract data. The reasons for exclusions during data extraction are shown in Appendix 4. A further 30 papers reported on ongoing studies that were yet to report their results.

FIGURE 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. a, Only applies to updated search where studies may have been identified in the earlier search. b, Some studies provided data that contributed to ≥ 1 review. (Figure not reproduced here; see the original article.)

Four papers62,63,64,65 reporting barriers and facilitators data were identified in the update searches, but as these papers did not contribute any new data to the review they were excluded but retained for inclusion in a future update. Overall, 52 papers (44 studies) were included in at least 1 of the 3 reviews (Reviews 1–3). The overlap between the reviews is shown in Figure 2 and a list of the studies included in each review is shown in Table 5.

TABLE 5 Studies contributing data to each of the four reviews
Review dataIncluded studies (N)References
Individual data
Effects only21Austin 2019,66 Bienek 2019,67 Cunningham 2016,68 Garland 2014,69 Gersch 2021,70 Hudak 2020,71 Huffman 2017,72 Jacobs 2016,73 Krumova 2013,74 Kurita 2018,75 Laigaard 2020,76 Montgomery 2020,77 Murphy 2013,78 Panicker 2022,79 Rivich 2018,80 Seal 2020,81 Sharp 2018,82 Thakral 201883 (linked papers: Von Korff 2016,84 2017,85 Sherman 2018,86 Thakral 201887), Townsend 2008,88 Twillman 2018,89 Zhou 201790
AEs only2Caldera 2020,91 Lalanne 201692
Barriers and facilitators only15Benintendi 2021,93 Firemark 2021,94 Kuntz 2021,95 Frank 2016,96 Giannitrapani 201897 (linked paper: Giannitrapani 201898), Henry 2019,99 Henry 2019100 (linked paper: Henry 2017101), Kennedy 2018,102 Langford 2020,103 Magee 2021,104 Matthias 2017,105 McNeilage 2022,106 Quinlan 2021,107 White 2020,108 Wu 2019109
Combined data
Effects and AEs5Capano 2020,110 Jackson 2021,111 Zheng 2008,112 Sullivan 2017113 (linked paper: NCT 2013114),115 Zheng 2019116 (linked paper: Xue 2012115)
Effects and barriers and facilitators1Westanmo 2015117
Inequalities42Austin 2019,66 Benintendi 2021,93 Bienek 2019,67 Capano 2020,110 Cunningham 2016,68 Firemark 2021,94 Frank 2016,96 Garland 2014,69 Gersch 2021,70 Giannitrapani 2018,97,98 Henry 2019,99 Henry 2019,100,101 Hudak 2020,71 Huffman 2017,72 Jackson 2021,111 Jacobs 2016,73 Kennedy 2018,102 Krumova 2013,74 Kuntz 2021,95 Kurita 2018,75 Laigaard 2020,76 Langford 2020,103 Magee 2021,104 Matthias 2017,105 McNeilage 2022,106 Montgomery 2020,77 Murphy 2013,78 Panicker 2022,79 Quinlan 2021,107 Rivich 2018,80 Seal 2020,81 Sharp 2018,82 Sullivan 2017,113 Thakral 201883,87 (linked papers: Von Korff 2016,84 2017,85 Sherman 201886), Townsend 2008,88 Twillman 2018,89 Westanmo 2015,117 White 2020,108 Wu 2019,109 Zheng 2008,112 Zheng 2019,116 Zhou 201790

FIGURE 2 Overlap of studies between reviews. B&F, barriers and facilitators. (Figure not reproduced here; see the original article.)

← Systematic review methodsEffectiveness of interventions to reduce opioid use →

Attribution. Ruaraidh Hill; Michelle Maden; Rui Duarte; Sam Eldabe; Su Golder; Marty Chaplin et al. (2026). Interventions to safely and effectively reduce (taper) use of opioids in chronic non-cancer pain: a systematic review. National Institute for Health and Care Research. Copyright © 2026 Hill et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK621520. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • Search results for all reviews

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support